| Mississippicare126 | |
|
232 Starlyn Ave New Albany MS 38652-2428 | |
| (662) 486-5122 | |
| (662) 486-5123 |
| Full Name | Mississippicare126 |
|---|---|
| Speciality | Clinic/Center |
| Location | 232 Starlyn Ave, New Albany, Mississippi |
| Authorized Official Name and Position | Steven Collier (CEO) |
| Authorized Official Contact | 8703473300 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mississippicare126 Po Box 497 Augusta AR 72006-0497 Ph: (870) 347-2534 | Mississippicare126 232 Starlyn Ave New Albany MS 38652-2428 Ph: (662) 486-5122 |
| NPI Number | 1396439899 |
|---|---|
| Provider Enumeration Date | 06/07/2023 |
| Last Update Date | 02/13/2024 |
| Medicare PECOS PAC ID | 2567370620 |
|---|---|
| Medicare Enrollment ID | O20230913001261 |
News Archive
The Food and Drug Administration (FDA) is re-issuing its warning to consumers not to drink "Jermuk" brand mineral water due to the risk of exposure to arsenic, a toxic substance and a known cause of cancer in humans.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).
The National Science Foundation (NSF) has awarded $6 million to fund three projects involving researchers from the Georgia Institute of Technology. Each four-year, $2 million grant was awarded through the NSF's Division of Emerging Frontiers in Research and Innovation.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396439899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
The Food and Drug Administration (FDA) is re-issuing its warning to consumers not to drink "Jermuk" brand mineral water due to the risk of exposure to arsenic, a toxic substance and a known cause of cancer in humans.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while Amgen/Pfizer's Enbrel was the most widely used tumor necrosis factor (TNF)-alpha inhibitor for recently treated psoriatic arthritis patients in the fourth quarter of 2010, Abbott's Humira has superseded Enbrel as an early-line TNF-alpha inhibitor for newly diagnosed psoriatic arthritis patients. Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis.
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).
The National Science Foundation (NSF) has awarded $6 million to fund three projects involving researchers from the Georgia Institute of Technology. Each four-year, $2 million grant was awarded through the NSF's Division of Emerging Frontiers in Research and Innovation.
› Verified 5 days ago
Durrett Health Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1515 Munsford Dr, New Albany, MS 38652 Phone: 662-534-0046 | |
The Center For Weight Loss, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 107 Main St W, New Albany, MS 38652 Phone: 662-534-0890 | |
New Albany Medical Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 400 Doctors Dr, New Albany, MS 38652 Phone: 662-534-5036 | |
Creekmore Clinic, P.l.l.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 216 Oxford Road, New Albany, MS 38652 Phone: 662-534-9042 Fax: 662-534-9707 | |
Express Care Of New Albany Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 210 Hwy 30 W, New Albany, MS 38652 Phone: 662-507-3330 Fax: 662-507-3333 | |
Heart Attack And Stroke Prevention Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 226 Starlyn Ave, New Albany, MS 38652 Phone: 404-852-7910 | |
New Albany Hospitalists Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 State Highway 30 W, New Albany, MS 38652 Phone: 662-538-2425 Fax: 662-538-2593 |